At Lorenc Aesthetic Plastic Surgery, we are thrilled to announce that we are one of the first practices in the country to offer Letybo®, the latest FDA-approved botulinum toxin for wrinkle reduction. This exciting new addition to the market marks the sixth neuromodulator approved in the U.S., providing more options for patients seeking safe, effective, and natural-looking facial rejuvenation.
Dr. Z. Paul Lorenc played an instrumental role in bringing this innovation to the aesthetic field by participating in the Phase III clinical trials for Letybo®, ensuring its safety and effectiveness before its official approval.
What is Letybo®, and Why is it Special?
Letybo® is a botulinum toxin type A injectable treatment designed to temporarily reduce the appearance of moderate to severe frown lines (glabellar lines) between the eyebrows. Manufactured by Hugel, Inc., a leading South Korean aesthetics company, Letybo® has been used internationally for years and is now officially FDA-approved for use in the United States.
Here’s why Letybo® is an exciting addition to the market:
✅ Highly Purified Formula – Letybo® is manufactured using an advanced purification process, ensuring a highly refined and consistent product for reliable results.
✅ Smooth, Natural-Looking Results – Clinical trials have shown that Letybo® delivers soft, subtle results that help maintain natural facial expressions while effectively smoothing wrinkles.
✅ Long-Lasting Effects – While results vary by patient, Letybo® has been formulated for durability comparable to leading neurotoxins, potentially lasting 3 to 6 months per treatment.
✅ Fast Onset – Many patients report seeing visible improvements within just a few days, with full results developing in about 7-14 days.
✅ Proven Safety & Effectiveness – Letybo® has been rigorously tested in global markets and is now backed by FDA approval for use in the U.S.
How Does Letybo® Compare to Other Neurotoxins?
Letybo® joins the family of botulinum toxin type A injectables, which include Botox®, Dysport®, Xeomin®, Jeuveau®, and Daxxify®. While all neurotoxins work by temporarily relaxing targeted facial muscles, Letybo® is designed to offer:
A highly purified formulation with fewer impurities
Precise, predictable diffusion, making it an excellent choice for smooth, natural-looking results
Proven efficacy, with strong clinical trial results showing significant improvement in frown lines
For patients who are already familiar with neurotoxins but want to explore a new alternative with refined technology, Letybo® is a compelling option!
Dr. Lorenc’s Role in the Clinical Trials
As a recognized leader in aesthetic medicine, Dr. Lorenc was directly involved in the Phase III trials of Letybo®, meaning he has an in-depth understanding of how to best utilize this innovative treatment. His firsthand experience with the product ensures that patients at Lorenc Aesthetic Plastic Surgery receive expertly customized injections tailored to their aesthetic goals.
Be Among the First to Experience Letybo®
Letybo® is now available at Lorenc Aesthetic Plastic Surgery, and we are excited to introduce this innovative neurotoxin to our patients. Whether you’re new to injectables or looking for a fresh approach to wrinkle reduction, our team is here to help you achieve beautiful, natural-looking results with the latest FDA-approved technology.
Comments